MiMedx Group, Inc. (MDXG)
NASDAQ: MDXG · Real-Time Price · USD
3.400
+0.060 (1.80%)
At close: Apr 28, 2026, 4:00 PM EDT
3.399
-0.001 (-0.02%)
After-hours: Apr 28, 2026, 5:27 PM EDT
MiMedx Group Market Cap
MiMedx Group has a market cap or net worth of $505.13 million as of April 28, 2026. Its market cap has decreased by -50.03% in one year.
Market Cap
505.13M
Enterprise Value
361.54M
1-Year Change
-50.03%
Ranking
Category
Stock Price
$3.40
Market Cap Chart
Since February 12, 2008, MiMedx Group's market cap has increased from $34.30M to $505.13M, an increase of 1,372.67%. That is a compound annual growth rate of 15.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 496.20M | -50.51% |
| Dec 31, 2025 | 1.00B | -29.07% |
| Dec 31, 2024 | 1.41B | 38.51% |
| Dec 29, 2023 | 1.02B | 222.97% |
| Dec 30, 2022 | 316.00M | -53.35% |
| Dec 31, 2021 | 677.40M | -32.82% |
| Dec 31, 2020 | 1.01B | 19.81% |
| Dec 31, 2019 | 841.60M | 323.34% |
| Dec 31, 2018 | 198.80M | -85.80% |
| Dec 29, 2017 | 1.40B | 44.30% |
| Dec 30, 2016 | 970.30M | -4.97% |
| Dec 31, 2015 | 1.02B | -17.19% |
| Dec 31, 2014 | 1.23B | 44.18% |
| Dec 31, 2013 | 855.20M | 156.74% |
| Dec 31, 2012 | 333.10M | 297.02% |
| Dec 30, 2011 | 83.90M | -2.67% |
| Dec 31, 2010 | 86.20M | 173.65% |
| Dec 31, 2009 | 31.50M | -81.05% |
| Dec 31, 2008 | 166.20M | 384.55% |
View and export this data all the way back to 2008.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zura Bio | 517.10M |
| Upstream Bio | 515.63M |
| AgomAb Therapeutics NV | 512.22M |
| Lyell Immunopharma | 503.43M |
| Fulcrum Therapeutics | 500.42M |
| XOMA Royalty | 497.12M |
| Valneva SE | 485.14M |
| ADC Therapeutics | 484.59M |